CONNECT Cancer Survivors With Tobacco Treatment

ConditionsTobacco Use Tobacco Use Cessation Smoking Cessation Nicotine Addiction Tobacco Smoking

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorWashington University School of Medicine

About this trial

The purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic cluster randomized trial (CRT) to test the effectiveness of nudges to change (ELEVATE-S) vs. quit-focused usual care (ELEVATE) in increasing tobacco treatment (use of medication, brief advice, or referral to external counseling) and smoking cessation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Be receiving care at a participating clinic

Report current tobacco use (assessed by the rooming staff during the index visit)

Have a completed appointment with a participating clinic

Be an adult (at least 18 years old).

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

ELEVATE
Behavioral
ELEVATE uses implementation strategies to support clinicians (support clinicians by revising professional roles to enable point of care tobacco treatment with a team are approach and support clinicians by providing clinical decision support tools).
ELEVATE-S
Behavioral
ELEVATE-S uses implementation strategies to support clinicians (support clinicians by revising professional roles to enable point of care tobacco treatment with a team are approach and support clinicians by providing clinical decision support tools) and implementation strategies to support patients with chronic care model-informed self-management support (patient centered flexible goals and patient-generated health data).

Treatment groups

5,000 Participants

are divided into 2 treatment groups

Group A: Electronic health record-enabled evidence-based tobacco treatment (ELEVATE)Active comparator 1 intervention

Group B: Electronic health record-enabled evidence-based tobacco treatment-Support (ELEVATE-S)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

Patient receipt of tobacco use treatment, i.e. Tobacco use treatment (TUT) Reach

This will be quantified by the proportion of enrolled patients who receive tobacco use treatment (either medication or behavioral intervention (brief advice or referral to counseling)).

Time frame

Up to 6 months post-enrollment

Secondary outcomes

Patient receipt of tobacco use treatment - behavioral intervention.

This will be quantified by the proportion of enrolled patients who receive tobacco use treatment behavioral intervention (brief advice or referral to counseling).

Time frame

Up to 6 months post-enrollment

Patient receipt of tobacco use treatment - medication.

This will be quantified by the proportion of enrolled patients who receive tobacco use treatment medication.

Time frame

Up to 6 months post-enrollment

Patient smoking abstinence

This will be quantified by the proportion of patients who smoke with EHR-documented smoking abstinence

Time frame

Up to 6 months post-enrollment

Other outcomes

Patient receipt of tobacco use treatment, i.e. Tobacco use treatment (TUT) Reach

This will be quantified by the proportion of enrolled patients who receive tobacco use treatment (either medication or behavioral intervention (brief advice or referral to counseling).

Time frame

Up to 12 months post-enrollment

Patient receipt of tobacco use treatment - behavioral intervention.

This will be quantified by the proportion of enrolled patients who receive tobacco use treatment behavioral intervention (brief advice or referral to counseling).

Time frame

Up to 12 months post-enrollment

Patient receipt of tobacco use treatment - medication.

This will be quantified by the proportion of enrolled patients who receive tobacco use treatment medication.

Time frame

Up to 12 months post-enrollment

Patient smoking abstinence

This will be quantified by the proportion of patients who smoke with EHR-documented smoking abstinence

Time frame

Up to 12 months post-enrollment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Washington University School of Medicine

Lead sponsor

Source ClinicalTrials.gov

Apply now